Amedisys Revenue, Profits - AMED Quarterly Income Statement

Add to My Stocks
$50.96 $1.62 (3.28%) AMED stock closing price Aug 16, 2017 (Closing)

Financial statements provide us with a way to gain insights and undertake the fundamental analysis of a company. Checking Amedisys stock price alone is not sufficient. An income statement is one of the three key financial statements furnished by a company, the other two being the balance sheet and the cashflow statement. The income statement is always for an accounting period, typically for a year or quarter, and affects the stock. In this case, the AMED stock is bound to reflect the impact of the QoQ growth of $8.36M. 2017-Q2 revenue is $378.82M and has increased from $370.46M quarter on quarter as is evident when you compare the latest figures in the latest Amedisys profit and loss statement with those of the prior corresponding period. (See also:Amedisys assets and Amedisys free cash flow) View details of revenue and profits for Amedisys for latest & last 40 quarters.

show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec.2017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q1
Amedisys Net Sales or Revenues
Cost Of Goods Sold (COGS)219.77M215.78M212.6M212.12M206.5M201.83M192.49M186.77M175.69M170.96M
Amedisys Gross Profit
Research & Development Expense----------
Selling General & Admin Expense154.28M125.09M135.15M129.89M130.9M131.44M200.15M118.31M118.31M106.98M
Income Before Depreciation Depletion Amortization4.78M29.58M18.58M19.57M23.33M15.53M-54.25M21.36M20.14M23.62M
Depreciation Depletion Amortization4.54M4.41M5.02M5.21M4.97M4.47M-70.95M4.64M4.61M81.73M
Non Operating Income3.52M1.02M2.63M4.97M1.03M0.75M6.96M3.26M5.32M4.1M
Interest Expense1.2M1.06M1.62M1.13M1.3M1.11M1.02M4.93M2.41M2.42M
Amedisys Pretax Income
Provision for Income Taxes-1.96M9.92M5.62M6.69M7.24M4.38M9.57M6.46M7.56M-21.59M
Minority Interest0.07M0.06M0.07M0.06M0.14M0.1M0.17M0.13M0.23M0.17M
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations4.53M15.13M8.92M11.44M10.7M6.21M12.91M8.44M10.64M-35.01M
Extraordinary Items & Discontinued Operations----------
Amedisys Net Income (Profit/Loss)
Average Shares used to compute Diluted EPS34.32M34.07M33.87M33.82M33.71M33.51M33.74M33.63M33.46M32.74M
Average Shares used to compute Basic EPS33.63M33.44M33.37M33.31M33.2M32.92M33.2M33.13M33M32.74M
Income Before Nonrecurring Items21.37M16.02M15.03M12.14M14.11M10.91M13.45M11.53M14.53M9.79M
Income from Nonrecurring Items-16.91M-0.89M-6.11M-0.7M-3.41M-4.7M-0.54M-3.09M-3.89M-44.79M
Amedisys Earnings Per Share Basic Net
Amedisys Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items0.620.470.440.360.420.330.400.340.430.30
Preferred Dividends Acc Pd----------
Dividends Common----------
Dividend Per Share Common----------
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Income statement for another ticker

It is very helpful to read a report on Amedisys stock analysis. An investor must check the following items in an income statement:
  • Revenue: The money received by selling of goods or services comes under this line item. A QoQ growth (See: Amedisys revenue chart) implies that the company is growing, which has been the case with Amedisys. One must stay away from stocks whose revenues are declining.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. AMED stock had a healthy bottom line growth.
The income statement is also called statement of revenue and expense. The financials along with Amedisys historical stock prices provides a lot of details about the firm. .

Amedisys Income Statement - Key Financial Ratios

PE ratio (price earnings ratio)
PS ratio (
price sales ratio
Operating margin
Net profit margin
Dividend yield